Isofol Medical Stock Forward View - Simple Regression
| ISOFOL Stock | SEK 0.67 0.02 2.90% |
Isofol Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Isofol Medical stock prices and determine the direction of Isofol Medical AB's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Isofol Medical's historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time, the value of RSI of Isofol Medical's share price is approaching 44. This usually indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Isofol Medical, making its price go up or down. Momentum 44
Sell Extended
Oversold | Overbought |
Using Isofol Medical hype-based prediction, you can estimate the value of Isofol Medical AB from the perspective of Isofol Medical response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of Isofol Medical AB on the next trading day is expected to be 0.71 with a mean absolute deviation of 0.02 and the sum of the absolute errors of 1.03. Isofol Medical after-hype prediction price | SEK 0.67 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Isofol |
Isofol Medical Additional Predictive Modules
Most predictive techniques to examine Isofol price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Isofol using various technical indicators. When you analyze Isofol charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Isofol Medical Simple Regression Price Forecast For the 1st of February
Given 90 days horizon, the Simple Regression forecasted value of Isofol Medical AB on the next trading day is expected to be 0.71 with a mean absolute deviation of 0.02, mean absolute percentage error of 0.0005, and the sum of the absolute errors of 1.03.Please note that although there have been many attempts to predict Isofol Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Isofol Medical's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Isofol Medical Stock Forecast Pattern
| Backtest Isofol Medical | Isofol Medical Price Prediction | Buy or Sell Advice |
Isofol Medical Forecasted Value
In the context of forecasting Isofol Medical's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Isofol Medical's downside and upside margins for the forecasting period are 0.01 and 2.93, respectively. We have considered Isofol Medical's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Isofol Medical stock data series using in forecasting. Note that when a statistical model is used to represent Isofol Medical stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 110.5054 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.017 |
| MAPE | Mean absolute percentage error | 0.0237 |
| SAE | Sum of the absolute errors | 1.0342 |
Predictive Modules for Isofol Medical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Isofol Medical AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Isofol Medical After-Hype Price Density Analysis
As far as predicting the price of Isofol Medical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Isofol Medical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Isofol Medical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Isofol Medical Estimiated After-Hype Price Volatility
In the context of predicting Isofol Medical's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Isofol Medical's historical news coverage. Isofol Medical's after-hype downside and upside margins for the prediction period are 0.03 and 2.91, respectively. We have considered Isofol Medical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Isofol Medical is dangerous at this time. Analysis and calculation of next after-hype price of Isofol Medical AB is based on 3 months time horizon.
Isofol Medical Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Isofol Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Isofol Medical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Isofol Medical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.02 | 2.22 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.67 | 0.67 | 0.00 |
|
Isofol Medical Hype Timeline
Isofol Medical AB is currently traded for 0.67on Stockholm Exchange of Sweden. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Isofol is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at -0.02%. %. The volatility of related hype on Isofol Medical is about 0.0%, with the expected price after the next announcement by competition of 0.67. About 26.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.65. Some equities with similar Price to Book (P/B) outperform the market in the long run. Isofol Medical AB recorded a loss per share of 1.42. The entity had not issued any dividends in recent years. Assuming the 90 days trading horizon the next estimated press release will be uncertain. Check out Historical Fundamental Analysis of Isofol Medical to cross-verify your projections.Isofol Medical Related Hype Analysis
Having access to credible news sources related to Isofol Medical's direct competition is more important than ever and may enhance your ability to predict Isofol Medical's future price movements. Getting to know how Isofol Medical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Isofol Medical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ANNX | Annexin Pharmaceuticals AB | 0.00 | 0 per month | 0.00 | (0.19) | 6.86 | (7.21) | 23.53 | |
| IRLAB-A | IRLAB Therapeutics AB | 0.00 | 0 per month | 0.00 | (0.15) | 4.55 | (5.12) | 14.42 | |
| LIPUM | Lipum AB | 0.00 | 0 per month | 2.12 | 0.16 | 7.76 | (1.71) | 23.55 | |
| INIT | Initiator Pharma AS | 0.00 | 0 per month | 2.45 | 0 | 4.67 | (5.12) | 15.04 | |
| KDEV | Karolinska Development AB | 0.00 | 0 per month | 0.00 | (0.15) | 3.57 | (13.16) | 47.86 | |
| ERMA | Enorama Pharma AB | 0.00 | 0 per month | 0.00 | (0.16) | 8.81 | (9.05) | 27.04 | |
| BIOWKS | Bio Works Technologies AB | 0.00 | 0 per month | 3.55 | 0.09 | 8.89 | (5.68) | 22.00 | |
| CLS-B | Clinical Laserthermia Systems | 0.00 | 0 per month | 4.01 | 0.03 | 7.51 | (5.73) | 24.08 | |
| ALZ | Alzinova AB | 0.00 | 0 per month | 0.00 | (0.07) | 6.67 | (7.25) | 72.31 | |
| XBRANE | Xbrane Biopharma AB | 0.00 | 0 per month | 0.00 | (0.08) | 9.05 | (6.92) | 26.56 |
Other Forecasting Options for Isofol Medical
For every potential investor in Isofol, whether a beginner or expert, Isofol Medical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Isofol Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Isofol. Basic forecasting techniques help filter out the noise by identifying Isofol Medical's price trends.Isofol Medical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Isofol Medical stock to make a market-neutral strategy. Peer analysis of Isofol Medical could also be used in its relative valuation, which is a method of valuing Isofol Medical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Isofol Medical Market Strength Events
Market strength indicators help investors to evaluate how Isofol Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Isofol Medical shares will generate the highest return on investment. By undertsting and applying Isofol Medical stock market strength indicators, traders can identify Isofol Medical AB entry and exit signals to maximize returns.
Isofol Medical Risk Indicators
The analysis of Isofol Medical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Isofol Medical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting isofol stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.71 | |||
| Standard Deviation | 2.15 | |||
| Variance | 4.61 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Isofol Medical
The number of cover stories for Isofol Medical depends on current market conditions and Isofol Medical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Isofol Medical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Isofol Medical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Isofol Medical Short Properties
Isofol Medical's future price predictability will typically decrease when Isofol Medical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Isofol Medical AB often depends not only on the future outlook of the potential Isofol Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Isofol Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 107.5 M | |
| Cash And Short Term Investments | 379.4 M |
Other Information on Investing in Isofol Stock
Isofol Medical financial ratios help investors to determine whether Isofol Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Isofol with respect to the benefits of owning Isofol Medical security.